Glenn has more than 20 years’ experience leading product marketing and R&D for small and large companies in sensing and detection, across applications in human and environmental health. For the majority of this time, Glenn was at global life sciences company PerkinElmer, where he progressed through multiple senior roles advancing PerkinElmer’s environmental health technologies from high-end laboratory detection to field-based sensing across a number of markets such as food, air, water and pharmaceuticals. Glenn joined the Company in March 2015 and was appointed to the Board on December 1 2015.

Bevan Metcalf has more than 35 years’ of financial management experience with international companies primarily in the mining, technology and pharmaceuticals sectors, including Orion Corporation and GlaxoSmithKline. In the past 16 years, he has been involved with companies listed on the AIM market of the London Stock Exchange. Bevan is a Member of the Chartered Accountants – Australia and New Zealand, and he has a degree in Management Studies from the University of Waikato, New Zealand. Bevan was appointed to the Board of the Company on 18 December 2015.

Gerard Brandon is Chief Executive Officer of both DeepVerge plc and Cellulac plc. In 1996 he became founder and CEO of Alltracel Pharmaceuticals plc (“Alltracel”), where he built a team which oversaw numerous patents granted on refined cellulose. Alltracel was admitted to trading on AIM in 2001. In 2004, he was appointed as a Managing Partner for Farmabrand Private Equity. In March 2020, he was appointed as a Non-executive Chairman to Modern Water plc, which was subsequently acquired by DeepVerge plc (formerly Integumen plc) in November 2020. Gerard is a Fellow of the Ryan Academy of Entrepreneurs in Dublin.

Dr. Nigel Burton spent over 14 years as an investment banker at leading City institutions including UBS Warburg and Deutsche Bank, including as the Managing Director responsible for the energy and utilities industries. Nigel spent 15 years as Chief Financial Officer or Chief Executive Officer of a number of private and public companies. Nigel is currently a Non-executive Director of LSE Main Market listed BlackRock Throgmorton Investment Trust plc, and of the AIM quoted companies Digitalbox plc, eEnergy Group plc and Mobile Streams plc. In February 2020, he was appointed as a Non-executive Director of Modern Water plc, which was subsequently acquired by DeepVerge plc (formerly Integumen plc) in November 2020, following which he became a Non-executive Director of DeepVerge plc.

Glenn has more than 20 years’ experience leading product marketing and R&D for small and large companies in sensing and detection, across applications in human and environmental health. For the majority of this time, Glenn was at global life sciences company PerkinElmer, where he progressed through multiple senior roles advancing PerkinElmer’s environmental health technologies from high-end laboratory detection to field-based sensing across a number of markets such as food, air, water and pharmaceuticals. Glenn joined the Company in March 2015 and was appointed to the Board on December 1 2015.

Bevan Metcalf has more than 35 years’ of financial management experience with international companies primarily in the mining, technology and pharmaceuticals sectors, including Orion Corporation and GlaxoSmithKline. In the past 16 years, he has been involved with companies listed on the AIM market of the London Stock Exchange. Bevan is a Member of the Chartered Accountants – Australia and New Zealand, and he has a degree in Management Studies from the University of Waikato, New Zealand. Bevan was appointed to the Board of the Company on 18 December 2015.

Phil joined Microsaic Systems plc in 2014 as Engineering Manager, prior to being appointed Operations Director in 2017. Phil has held senior positions across fortune 500, medium and small-scale companies, operating in the high technology capital equipment sectors. Phil joined Microsaic from Oxford Instruments, Plasma Technology, a global provider of plasma tools used in the creation of MEMs devices, where he held the position of Engineering and Technology Director. Prior to this, Phil held senior positions, including programme management, New Product Introduction, Manufacturing Engineering and Operations at Applied Materials Inc.(Implant Division), a global leader in nano-manufacturing technology solutions and a supplier of semiconductor capital equipment,. A Graduate of the Warwick Manufacturing Group, he attained a Master’s Degree in Engineering Business Management and a First class BEng honors degree.

Richard joined Microsaic Systems in 2003 as a Product Engineer and progressed to Devices Manager. From 2006, he led a development team to make miniaturised, chip-based components using Micro-Electro-Mechanical Systems (MEMS) technology and has an extensive network of senior level relationships within micromachining fabs across the world. From 2010 he was Commercial manager supporting marketing-, sales- and servicing-related NPI activities of the MiD. Since 2016 Richard has moved into molecular diagnostics, establishing key strategic relationships with Biopharma. Between 2000 and 2003, Richard worked in various R&D and manufacturing sites at Agilent Technologies. He was awarded a BSc degree in Physics and Chemistry of Materials from the University of Durham, and obtained a PhD in Device Physics at the University of Cambridge.

Victoria joined Microsaic as applications engineer in 2015. Victoria has extensive knowledge in Mass Spectrometry, Liquid Chromatography-Mass Spectrometry (LC-MS), GMP and Analytical Chemistry.
Victoria graduated from Edinburgh University in 2013 where she was awarded a Masters in Chemistry. As part of her degree at Edinburgh she did a year in industry in their clinical applications lab at Waters and her masters project focused on the mass spectrometry of multimeric protein complexes. After graduating Victoria worked for Vista Analytical an environmental lab based in California doing environmental LCMS method development.

Steve Vigar has more than 20 years’ experience within the instrumentation industry, where he has held critical service roles in medical research and analytical instrumentation. Steve spent a significant time at Shimadzu, where he held the role of Regional Service manager for the UK. Steve joined Microsaic Systems plc, in July 2013 as Global Service Manager.

Bin has over 10 years’ both commercial and technical experience in analytical instruments. He has a broad range of experience across a range of analytical techniques such as IC, GC, ICP-MS, ICP-OES, AA and AFS, and specialises in Mass Directed analysis. A fluent speaker of Chinese, Bin is responsible for developing all business with OEM partners across APAC. Bin holds a PhD in Analytical Chemistry, Xiamen University in China, and he was awarded Alexander von Humboldt Fellowship when he held a postdoctoral position at Heidelberg University in Germany. In addition, Bin held the position of research fellow in the School of Public Health, at the University of Michigan.